Results 261 to 270 of about 564,677 (319)

Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery

open access: yesAggregate, EarlyView.
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail   +5 more
wiley   +1 more source

Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice. [PDF]

open access: yesNat Commun
Wang H   +14 more
europepmc   +1 more source

Cytoimmunological Profile of Lower Airways in Post-COVID-19 Syndrome (PCS): Predictive Value of Bronchoalveolar Lavage. [PDF]

open access: yesJ Clin Med
Dolna-Michno J   +8 more
europepmc   +1 more source

From Defense to Disease: How the Immune System Fuels Epithelial-Mesenchymal Transition in Ovarian Cancer. [PDF]

open access: yesInt J Mol Sci
Kos M   +7 more
europepmc   +1 more source

Polycytotoxic T cells mediate antimicrobial activity against intracellular <i>Mycobacterium tuberculosis</i>. [PDF]

open access: yesInfect Immun
Zumwinkel M   +7 more
europepmc   +1 more source

Apoptotic Effect of Combinations of T-2, HT-2, and Diacetoxyscirpenol on Human Jurkat T Cells. [PDF]

open access: yesToxins (Basel)
Wattanasuntorn P   +6 more
europepmc   +1 more source

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma. [PDF]

open access: yesESMO Open
Gramantieri L   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy